Education
About Us
Working with TipRanks
Follow Us
GlaxoSmithKline (GB:GSK)
LSE:GSK
GlaxoSmithKline (GSK) Ownership Overview
1.10% Insiders
11.26%
Mutual Funds
0.08% Other Institutional Investors
11.49% ETFs
76.07% Public Companies and
Individual Investors
The ownership structure of GlaxoSmithKline (GB:GSK) stock is a mix of institutional, retail, and individual investors. Approximately 22.83% of the company’s stock is owned by Institutional Investors, 1.10% is owned by Insiders, and 76.07% is owned by Public Companies and Individual Investors.
Recent Insider Trading Activity
Date | Name | Activity | Value |
|---|---|---|---|
| Feb 26, 2025 | J. Ford Senior Vice President & General Counsel | xxxxxxxxxxxxx | £151363 |
| Feb 21, 2025 | Hal Barron Chief Science Officer,director | xxxxxxxxxxxxx | $902078 |
| Feb 21, 2025 | Deborah Waterhouse Divisional Chief Executive Officer | xxxxxxxxxxxxx | £972909 |
| Feb 21, 2025 | David S Redfern Corporate Development Officer | xxxxxxxxxxxxx | £1148404 |
Top Shareholders
Holder | # of Shares | Type | % Holding | Value |
|---|---|---|---|---|
| 192,783,331 | Institution | 4.66% | 3,768,721,338 | |
| 140,960,305 | Institution | 3.41% | 2,755,633,002 | |
| 82,962,740 | Institution | 2.01% | 1,621,838,604 | |
| 55,785,220 | Institution | 1.35% | 1,090,545,266 | |
| 42,589,333 | Insider | 1.03% | 832,578,871 | |
| 41,330,791 | Institution | 1.00% | 807,975,633 | |
| 36,708,771 | Institution | 0.89% | 717,619,764 | |
| 34,635,632 | Institution | 0.84% | 677,091,970 | |
| 28,582,159 | Institution | 0.69% | 558,752,626 | |
| 25,928,382 | Institution | 0.63% | 506,873,940 |
Top Mutual Fund Holders
Holder | # of Shares | Type | % Holding | Value |
|---|---|---|---|---|
| 82,962,740 | Institution | 2.01% | 1,621,838,604 | |
| 55,785,220 | Institution | 1.35% | 1,090,545,266 | |
| 36,708,771 | Institution | 0.89% | 717,619,764 | |
| 34,635,632 | Institution | 0.84% | 677,091,970 | |
| 28,582,159 | Institution | 0.69% | 558,752,626 | |
| 25,928,382 | Institution | 0.63% | 506,873,940 | |
| 18,412,618 | Institution | 0.45% | 359,948,269 | |
| 13,823,936 | Institution | 0.33% | 270,244,125 | |
| 13,609,638 | Institution | 0.33% | 266,054,813 | |
| 13,276,740 | Institution | 0.32% | 259,546,990 |
Top ETF Holders
Holder | # of Shares | Type | % Holding | Value |
|---|---|---|---|---|
| 56,244,584 | Institution | 1.36% | 1,037,822,434 | |
| 34,868,597 | Institution | 0.84% | 643,392,933 | |
| 26,051,422 | Institution | 0.63% | 506,776,796 | |
| 13,794,067 | Institution | 0.33% | 268,335,183 | |
| 9,779,769 | Institution | 0.24% | 137,405,754 | |
| 8,112,327 | Institution | 0.20% | 149,688,095 | |
| 8,082,911 | Institution | 0.20% | 156,833,117 | |
| 7,900,601 | Institution | 0.19% | 145,781,342 | |
| 6,496,670 | Institution | 0.16% | 126,379,344 | |
| 5,964,912 | Institution | 0.14% | 90,428,066 |
FAQ
Who Owns GlaxoSmithKline (GB:GSK)?
According to the latest TipRanks data, approximately 0.08% of the company's stock is held by institutional investors, 1.10% is held by insiders, and 76.07% is held by retail investors.
What percentage of GlaxoSmithKline (GB:GSK) stock is held by institutional investors?
According to the latest TipRanks data, approximately 0.08% of GlaxoSmithKline (GB:GSK) stock is held by institutional investors.
What percentage of GlaxoSmithKline (GB:GSK) stock is held by retail investors?
According to the latest TipRanks data, approximately 76.07% of GlaxoSmithKline (GB:GSK) stock is held by retail investors.
Who owns the most shares of GlaxoSmithKline (GB:GSK)?
iShares owns the most shares of GlaxoSmithKline (GB:GSK).
What is the significance of the ownership structure for a publicly traded company?
The ownership structure can impact the company's decision making, as large institutional investors may exert influence on the company's management and can also affect the company's stock price with their buying and selling patterns.